Switch theme
Sign up to access all valuation multiples
China Resources Sanjiu Medical & Pharmaceutical Co Ltd is a China-based pharmaceutical company. It is engaged in the research and development, production and sale of pharmaceutical products, healthcare products, and medical appliances under the brand name 999, which includes OTC, antibiotic and raw material drug. The other brands under which the company offers its products are Lee King, Shunfeng, and Tianhe. The company's core business is located in OTC and Chinese medicine prescription drugs, OTC core products in the cold, gastrointestinal, skin, pediatric, cough and orthopedic drugs occupy a higher market share; prescription drug products in traditional Chinese medicine formula granules, cardiovascular and cerebrovascular, anti-tumor in the field of anti-infection and other areas.
1999
603
LTM Revenue $4.1B
LTM EBITDA $758M
$6.8B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
China Resources Sanjiu has a last 12-month revenue (LTM) of $4.1B and a last 12-month EBITDA of $758M.
In the most recent fiscal year, China Resources Sanjiu achieved revenue of $3.8B and an EBITDA of $764M.
China Resources Sanjiu expects next 12-month revenue of XXX and NTM EBITDA of XXX
See China Resources Sanjiu valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $4.1B | XXX | $3.8B | XXX | XXX | XXX |
| Gross Profit | $2.1B | XXX | $2.0B | XXX | XXX | XXX |
| Gross Margin | 52% | XXX | 52% | XXX | XXX | XXX |
| EBITDA | $758M | XXX | $764M | XXX | XXX | XXX |
| EBITDA Margin | 19% | XXX | 20% | XXX | XXX | XXX |
| EBIT | $658M | XXX | $643M | XXX | XXX | XXX |
| EBIT Margin | 16% | XXX | 17% | XXX | XXX | XXX |
| Net Profit | $495M | XXX | $467M | XXX | XXX | XXX |
| Net Margin | 12% | XXX | 12% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, China Resources Sanjiu's stock price is CNY 43 (or $6).
China Resources Sanjiu has current market cap of CNY 55.2B (or $7.7B), and EV of CNY 49.3B (or $6.8B).
See China Resources Sanjiu trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $6.8B | $7.7B | XXX | XXX | XXX | XXX | $0.39 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, China Resources Sanjiu has market cap of $7.7B and EV of $6.8B.
China Resources Sanjiu's trades at 1.8x EV/Revenue multiple, and 9.0x EV/EBITDA.
Equity research analysts estimate China Resources Sanjiu's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
China Resources Sanjiu has a P/E ratio of 15.5x.
See valuation multiples for China Resources Sanjiu and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $7.7B | XXX | $7.7B | XXX | XXX | XXX |
| EV (current) | $6.8B | XXX | $6.8B | XXX | XXX | XXX |
| EV/Revenue | 1.7x | XXX | 1.8x | XXX | XXX | XXX |
| EV/EBITDA | 9.0x | XXX | 9.0x | XXX | XXX | XXX |
| EV/EBIT | 10.4x | XXX | 10.6x | XXX | XXX | XXX |
| EV/Gross Profit | 3.2x | XXX | n/a | XXX | XXX | XXX |
| P/E | 15.5x | XXX | 16.4x | XXX | XXX | XXX |
| EV/FCF | 13.4x | XXX | 13.6x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialChina Resources Sanjiu's last 12 month revenue growth is 13%
China Resources Sanjiu's revenue per employee in the last FY averaged $6.4M, while opex per employee averaged $2.2M for the same period.
China Resources Sanjiu's rule of 40 is 32% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
China Resources Sanjiu's rule of X is 52% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for China Resources Sanjiu and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 13% | XXX | 13% | XXX | XXX | XXX |
| EBITDA Margin | 19% | XXX | 20% | XXX | XXX | XXX |
| EBITDA Growth | 13% | XXX | 12% | XXX | XXX | XXX |
| Rule of 40 | 32% | XXX | 33% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 52% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $6.4M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $2.2M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 21% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 3% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 35% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Julphar | XXX | XXX | XXX | XXX | XXX | XXX |
| Galapagos | XXX | XXX | XXX | XXX | XXX | XXX |
| Pharming | XXX | XXX | XXX | XXX | XXX | XXX |
| Vivoryon Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| Armata Pharmaceuticals | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
China Resources Sanjiu acquired XXX companies to date.
Last acquisition by China Resources Sanjiu was XXXXXXXX, XXXXX XXXXX XXXXXX . China Resources Sanjiu acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was China Resources Sanjiu founded? | China Resources Sanjiu was founded in 1999. |
| Where is China Resources Sanjiu headquartered? | China Resources Sanjiu is headquartered in China. |
| How many employees does China Resources Sanjiu have? | As of today, China Resources Sanjiu has 603 employees. |
| Is China Resources Sanjiu publicy listed? | Yes, China Resources Sanjiu is a public company listed on SHE. |
| What is the stock symbol of China Resources Sanjiu? | China Resources Sanjiu trades under 000999 ticker. |
| When did China Resources Sanjiu go public? | China Resources Sanjiu went public in 2000. |
| Who are competitors of China Resources Sanjiu? | Similar companies to China Resources Sanjiu include e.g. Julphar, Galapagos, Pharming, Vivoryon Therapeutics. |
| What is the current market cap of China Resources Sanjiu? | China Resources Sanjiu's current market cap is $7.7B |
| What is the current revenue of China Resources Sanjiu? | China Resources Sanjiu's last 12 months revenue is $4.1B. |
| What is the current revenue growth of China Resources Sanjiu? | China Resources Sanjiu revenue growth (NTM/LTM) is 13%. |
| What is the current EV/Revenue multiple of China Resources Sanjiu? | Current revenue multiple of China Resources Sanjiu is 1.7x. |
| Is China Resources Sanjiu profitable? | Yes, China Resources Sanjiu is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of China Resources Sanjiu? | China Resources Sanjiu's last 12 months EBITDA is $758M. |
| What is China Resources Sanjiu's EBITDA margin? | China Resources Sanjiu's last 12 months EBITDA margin is 19%. |
| What is the current EV/EBITDA multiple of China Resources Sanjiu? | Current EBITDA multiple of China Resources Sanjiu is 9.0x. |
| What is the current FCF of China Resources Sanjiu? | China Resources Sanjiu's last 12 months FCF is $509M. |
| What is China Resources Sanjiu's FCF margin? | China Resources Sanjiu's last 12 months FCF margin is 12%. |
| What is the current EV/FCF multiple of China Resources Sanjiu? | Current FCF multiple of China Resources Sanjiu is 13.4x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
